Mehrsa Majdaeen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mehrsa Majdaeen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Amin Banaei
Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 shared publications- Bagher Farhood
Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan, Iran
2 shared publications Gholamreza Ataei
Department of Radiology Technology, Faculty of Paramedical Sciences, Babol University of Medical Science, Babol, Iran
2 shared publicationsHamed Zamani
Department of Medical Physics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 shared publications- Razzagh Abedi-Firouzjah
Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 shared publications Tayebeh Aryafar
Department of Radiation Sciences, Yasuj University of Medical Sciences, Yasuj, Iran
2 shared publications
Latest Publications
- 20 January 2024
- Published by Elsevier in Pathology - Research and Practice
- Vol. 254, 155159
Functions of Sialyltransferases in gynecological malignancies: A systematic review
- 20 January 2024
- Published by Elsevier in Pathology - Research and Practice
- Vol. 254, 155159
Functions of Sialyltransferases in gynecological malignancies: A systematic review
- Open Access
- 1 October 2021
- Published by CMV Verlag in International Journal of Radiation Research
- Vol. 19 (4) , 913-920
Radiation protection and cytotoxicity effects of different concentrations of cerium oxide nanoparticles in aqueous solution combined with sodium dodecyl sulphate in Vero cells irradiated with 18 MV beams
Background: This study aimed to assess and compare the radioprotective and cytotoxic effects of various concentrations of cerium oxide nanoparticles (CONPs) in aqueous solution combined with sodium dodecyl sulphate (SDS) against high energy X-ray beams in Vero cells. Materials and Methods: The scanner electron microscopy (SEM) method was used to ...
- 1 October 2021
- Published by CMV Verlag in International Journal of Radiation Research
- Vol. 19 (4) , 913-920
Open AccessRadiation protection and cytotoxicity effects of different concentrations of cerium oxide nanoparticles in aqueous solution combined with sodium dodecyl sulphate in Vero cells irradiated with 18 MV beams
Background: This study aimed to assess and compare the radioprotective and cytotoxic effects of various concentrations of cerium oxide nanoparticles (CONPs) in aqueous solution combined with sodium dodecyl sulphate (SDS) against high energy X-ray beams in Vero cells. Materials and Methods: The scanner electron microscopy (SEM) method was used to ...
- 1 September 2021
- Published by Elsevier in Life Sciences
- Vol. 281, 119721
The role of melatonin on radiation-induced pneumonitis and lung fibrosis: A systematic review
- 1 September 2021
- Published by Elsevier in Life Sciences
- Vol. 281, 119721
The role of melatonin on radiation-induced pneumonitis and lung fibrosis: A systematic review
- Open Access
- 21 July 2021
- Published by Springer Nature in Cancer Cell International
- Vol. 21 (1) , 1-15
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review
Glioblastoma, WHO grade IV astrocytoma, is the most aggressive type of brain tumors. These cancerous cells have a rapid growth rate, tendency to penetrate vital brain structures, molecular heterogeneity, etc. and this cancer is associated with a poor prognosis and low survival rate. Due to the resistance of glioblastoma cells to conventional therapeutic modalities (such as radiation therapy and chemotherapy) as well as the adverse effects of these modalities, the researchers have attempted to discover an appropriate alternative or adjuvant treatment for glioblastoma. Resveratrol, as an herbal and natural polyphenolic compound, has anti-tumoral property and has shown to be effective in GBM treatment. Resveratrol exerts its anti-tumoral effect through various mechanisms such as regulation of cell cycle progression and cell proliferation, autophagy, oxidant system, apoptosis pathways, and so on. Resveratrol in combination with radiation therapy and chemotherapy has also been used. In the present study, we summarized the current findings on therapeutic potentials of resveratrol in glioblastoma radiotherapy and chemotherapy.
- 21 July 2021
- Published by Springer Nature in Cancer Cell International
- Vol. 21 (1) , 1-15
Open AccessTherapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review
Glioblastoma, WHO grade IV astrocytoma, is the most aggressive type of brain tumors. These cancerous cells have a rapid growth rate, tendency to penetrate vital brain structures, molecular heterogeneity, etc. and this cancer is associated with a poor prognosis and low survival rate. Due to the resistance of glioblastoma cells to conventional therapeutic modalities (such as radiation therapy and chemotherapy) as well as the adverse effects of these modalities, the researchers have attempted to discover an appropriate alternative or adjuvant treatment for glioblastoma. Resveratrol, as an herbal and natural polyphenolic compound, has anti-tumoral property and has shown to be effective in GBM treatment. Resveratrol exerts its anti-tumoral effect through various mechanisms such as regulation of cell cycle progression and cell proliferation, autophagy, oxidant system, apoptosis pathways, and so on. Resveratrol in combination with radiation therapy and chemotherapy has also been used. In the present study, we summarized the current findings on therapeutic potentials of resveratrol in glioblastoma radiotherapy and chemotherapy.